{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "TRUP",
  "name": "Trupanion, Inc.",
  "url": "https://frontierpicks.com/dossiers/TRUP/",
  "json_url": "https://frontierpicks.com/dossiers/TRUP.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Trupanion's pet-insurance subscriptions are growing revenue 14% with a widening margin, but the shares already sit near most analyst targets; the 5 November 2026 third-quarter report shows whether margin gains outrun slow pet growth.",
  "invalidation_trigger": "A daily close below $24.40, which would erase the whole rise since the late-July close near $24.48; a subscription adjusted operating margin below 15.0% in the third-quarter report would also break the case.",
  "catalyst_date": "2026-11-05",
  "pick": null,
  "themes": [
    "fintech-consumer-credit"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Trupanion reports two segments, subscription and other business; the subscription segment carries the margin story and most of the growth.",
    "Cash held at the insurance subsidiary reaches the parent only through regulator-approved dividends, such as the $44 million New York approved in July 2026.",
    "Repurchases under the $100 million authorization depend on compliance with the company's PNC credit facility and on available cash."
  ],
  "body_markdown": "## Current Thesis\nTrupanion's pet-insurance subscription business is growing revenue in the mid-teens and widening its margin, but the shares have already climbed back to the targets most covering analysts publish. The third-quarter report on 2026-11-05 decides it: margin gains have to outrun slower pet growth and rising vet costs for the shares to lead the market from here.\n\nThe core business is improving on the numbers. In its second-quarter release on 2026-08-05, Trupanion reported subscription revenue of $276.7 million, up 14%, and a subscription adjusted operating margin of 15.0%, against 13.8% a year earlier. Monthly average retention was 98.37%. The company also authorized a $100 million share repurchase with no expiry.\n\nPet growth is the weaker half. Subscription pets rose 5% to 1,124,548 at 2026-06-30, while total enrolled pets across both segments fell 2% to 1,633,131. Most of the revenue growth is coming from price rather than new pets. That works only while customers accept the increases.\n\nThe narrative is maturing: the margin-recovery story is well known, and two brokers have moved to neutral or cut targets since Piper Sandler's downgrade on 2026-08-26. With the adjusted close at $29.21 on 2026-10-27, the shares sit near Cantor Fitzgerald's $30 target and Piper Sandler's $32 target. The evidence supports a working business with no clear edge over the S&P 500 into the report.\n\n## Bull Case\n- **Subscription margin is expanding.** Subscription adjusted operating income rose 24% to $41.4 million in the second quarter of 2026, a 15.0% margin against 13.8% a year earlier, per the company's 2026-08-05 release.\n- **Retention stays near record levels.** Monthly average retention was 98.37% in the 2026-08-05 release. High retention means price increases have not yet driven customers away.\n- The board authorized a $100 million repurchase, and New York regulators approved a $44 million dividend from the insurance subsidiary in July 2026.\n- **Consensus target sits above the price.** MarketBeat's consensus target was $38.40 on 2026-10-24, about 31% above the $29.21 close on 2026-10-27, though that average includes targets set up to a year ago.\n\n## Bear Case\n- **Pet growth is slow.** Subscription pets grew only 5% year over year at 2026-06-30, and total enrolled pets fell 2%, per the 2026-08-05 release.\n- **Vet cost inflation squeezes pricing.** Piper Sandler cut Trupanion to Neutral on 2026-08-26 and lowered its target from $45 to $32, citing weak US puppy vet visits, an aging insured pet population with costlier claims, and consumers less able to absorb premium increases.\n- **Recent targets cluster near the price.** Cantor Fitzgerald cut its target to $30 from $34 on 2026-10-07 and kept a Neutral rating. Stifel's Hold target is $29. MarketBeat counted five Hold ratings and one Buy on 2026-10-24.\n- **Thin profit below the operating line.** Net income was $6.8 million, or $0.16 per share, in the second quarter of 2026, down from $9.4 million a year earlier, which included a $7.8 million one-time gain.\n\n## Setup & Price Structure\nThe adjusted close on 2026-10-27 was $29.21. That is 32.9% below the 52-week high of $43.51 and 19.3% above the level of three months earlier. The rise since late July carried the shares from roughly $24.48, the price MarketBeat cited on 2026-07-28, to the high $20s.\n\nThe 14-day relative strength index (RSI), a momentum gauge where readings above 70 mark stretched buying, stood at 76.5 on 2026-10-27. A stretched reading seven trading days before an earnings report increases the chance of a sharp move either way on the print. The shares trade around the $29 to $32 targets of Stifel, Cantor Fitzgerald and Piper Sandler, so the brokers who updated most recently see little room above the current price.\n\nCrowding is visible in the momentum reading and the near earnings date. There is no sign of heavy retail attention or share issuance into the rise.\n\n## Catalyst Calendar (next 30 days)\n- **2026-11-05, after the close — third-quarter 2026 report and call.** The company confirmed the date on 2026-10-20. It shows whether the subscription margin holds at or above 15.0%, whether subscription pet growth stays near 5%, and whether management keeps the full-year outlook. MarketBeat's summary of the 2026-08-05 call reported full-year revenue guidance of $1.584 billion to $1.601 billion and adjusted operating income guidance narrowed to $176 million to $184 million.\n- **~2026-11-06, est. quarterly 10-Q filing.** The filing shows how much of the $100 million repurchase was used in the third quarter.\n\n## What Would Change Our Mind\nThe case breaks if the third-quarter report shows the subscription adjusted operating margin falling below the 15.0% reached in the second quarter. A narrowed margin would mean vet cost inflation is outrunning price increases, as Piper Sandler argued on 2026-08-26. A cut to the $176 million to $184 million full-year adjusted operating income range, or subscription pet growth dropping below 5%, would point the same way.\n\nOn price, a daily close below $24.40 would give back the whole rise since late July and mark the end of the recovery. The read would turn more positive if the report shows margin above 15.0% with pet growth holding, and if a broker lifts its target well above the $29 to $32 cluster on the result.\n\n## Correlation Notes\nTrupanion sits with MAX, NRDS, HIPO and SLDE in the fintech and consumer-credit group, which has been cooling since late July. Its drivers differ from the lenders and comparison sites in that group: they are veterinary cost inflation, new pet adoption and US consumers' tolerance for premium increases. The closest peer by business is Hippo, another consumer insurer where claims cost and pricing set the margin. A cooling group raises the bar for this name, so the read rests on Trupanion's own report. A broad pullback in consumer-facing financial stocks would weigh on the shares even if the quarter is clean.",
  "first_seen": "2026-10-27",
  "last_analyzed": "2026-10-28T05:03:05+00:00",
  "last_synthesized": "2026-10-28",
  "last_update_source": "research_universe",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}